Quantitative vascular measurements in arterial occlusive disease
Accuracy in quantifying arterial occlusive disease requires an understanding of the relevant
technical considerations and familiarity with the strengths and weaknesses of various …
technical considerations and familiarity with the strengths and weaknesses of various …
Regorafenib plus nivolumab in patients with advanced gastric or colorectal cancer: an open-label, dose-escalation, and dose-expansion phase Ib trial (REGONIVO …
S Fukuoka, H Hara, N Takahashi, T Kojima… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE This is a phase Ib trial of regorafenib plus nivolumab for gastric and colorectal
cancer. PATIENTS AND METHODS Enrolled patients received regorafenib plus nivolumab …
cancer. PATIENTS AND METHODS Enrolled patients received regorafenib plus nivolumab …
Malignant Astrocytic Tumors: Clinical Importance of Apparent Diffusion Coefficient in Prediction of Grade and Prognosis1
S Higano, X Yun, T Kumabe, M Watanabe, S Mugikura… - Radiology, 2006 - pubs.rsna.org
Purpose: To retrospectively assess the apparent diffusion coefficient (ADC) for prediction of
malignancy and prognosis of malignant astrocytic tumors. Materials and Methods: The …
malignancy and prognosis of malignant astrocytic tumors. Materials and Methods: The …
High performance dye-sensitized solar cells using ionic liquids as their electrolytes
R Kawano, H Matsui, C Matsuyama, A Sato… - … of Photochemistry and …, 2004 - Elsevier
Room temperature ionic liquids have been used as electrolytes to investigate the
performance and the characteristics in dye-sensitized solar cells (DSSCs). The ionic liquids …
performance and the characteristics in dye-sensitized solar cells (DSSCs). The ionic liquids …
[HTML][HTML] Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial
Y Nakamura, W Okamoto, T Kato, T Esaki, K Kato… - Nature medicine, 2021 - nature.com
The applicability of circulating tumor DNA (ctDNA) genotyping to inform enrollment of
patients with cancer in clinical trials has not been established. We conducted a phase 2 trial …
patients with cancer in clinical trials has not been established. We conducted a phase 2 trial …
A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708)
H Kato, A Sato, H Fukuda, Y Kagami… - Japanese journal of …, 2009 - academic.oup.com
Objective The study objective was to evaluate the efficacy and toxicity of chemoradiotherapy
with 5-fluorouracil (5-FU) plus cisplatin in patients with Stage I esophageal squamous cell …
with 5-fluorouracil (5-FU) plus cisplatin in patients with Stage I esophageal squamous cell …
Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial
K Yoh, T Seto, M Satouchi, M Nishio… - The Lancet …, 2017 - thelancet.com
Background RET rearrangements are rare oncogenic alterations in non-small-cell lung
cancer (NSCLC). Vandetanib is a multitargeted tyrosine kinase inhibitor exhibiting RET …
cancer (NSCLC). Vandetanib is a multitargeted tyrosine kinase inhibitor exhibiting RET …
Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial
A Kawazoe, S Fukuoka, Y Nakamura, Y Kuboki… - The Lancet …, 2020 - thelancet.com
Background Pembrolizumab, an anti-PD-1 antibody, results in tumour response in around
15% of patients with advanced gastric cancer who have a PD-L1 combined positive score of …
15% of patients with advanced gastric cancer who have a PD-L1 combined positive score of …
[HTML][HTML] Non-equilibrium steady states in supramolecular polymerization
A Sorrenti, J Leira-Iglesias, A Sato… - Nature …, 2017 - nature.com
Living systems use fuel-driven supramolecular polymers such as actin to control important
cell functions. Fuel molecules like ATP are used to control when and where such polymers …
cell functions. Fuel molecules like ATP are used to control when and where such polymers …
Preoperative chemoradiotherapy plus nivolumab before surgery in patients with microsatellite stable and microsatellite instability–high locally advanced rectal cancer
H Bando, Y Tsukada, K Inamori, Y Togashi… - Clinical Cancer …, 2022 - AACR
Purpose: Preoperative chemoradiotherapy (CRT) and surgical resection are the standard
treatment for locally advanced rectal cancer (LARC). Combining immune checkpoint …
treatment for locally advanced rectal cancer (LARC). Combining immune checkpoint …